Setting long-term mortality improvement assumptions is an essential topic for anyone working in Life or Annuities practice.
This session will explore the quantitative and qualitative factors to include when observing past events and forecasting future developments to help set these assumptions.
We will examine global and national trends, medical advances, and new technologies as well as exploring the evidence from the recent Swiss Re publication on Life Trends.
Swiss Re
Adam joined Swiss Re Institute in 2019 as a Life and Health R&D Manager. He leads on COVID-19 insights, thought leadership, and external academic partnerships.
He ran internal and external briefings on COVID-19 throughout the pandemic on the behaviour of COVID-19, and leads external-facing thought leadership on a range of topics in L&H. Additionally, he now focuses on the ongoing challenges and impacts of COVID-19 on health over time. On other topics, he is currently coordinating research partnerships on population medicine, predicting future markers of health and disease.
Adam holds a PhD in diagnostic medicine from University College London in the UK, and is a visiting senior research fellow at University College Hospital and University College London.
Swiss Re
Daniel holds a diploma in Mathematics and a Ph.D. with honours in Computer Science, both from the University of Konstanz in Germany. He joined Swiss Re in 2008, working in Risk Management where he was essential for the development of Swiss Re's Group Risk Model used for regulators and internal capital allocation.
Daniel is a fully qualified actuary of the Swiss Actuarial Association, where he also actively contributes to the Data Science working group, and joined the Swiss Re Institute as a member of the Life & Behaviour R&D team in 2020, where he is working on individual health forecasting models.